CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 11 enrolled
Drug / intervention
TMS treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04076644
NCT04076644N/ACompleted
CompareCT.gov

Maintenance of Response To Transcranial Magnetic Stimulation (TMS) in Major Depressive Disorder (MDD) Using Monthly TMS Treatment

University of Missouri-Columbia·interventional·Posted Sep 3, 2019·Updated Jan 4, 2023

In Brief

A clinical study evaluating TMS treatment for MDD. Completed, enrolled 11 participants across 1 site.

Detailed Summary

This an open label study using a FDA-cleared TMS stimulation protocols which will be used to treat patients who have responded or remitted from depression using acute clinical TMS therapy at the University of Missouri-Columbia Neuromodulation Clinic. TMS therapy will be given to subjects at monthly intervals. Depression severity questionnaires will be given monthly to determine if the subjects original response to TMS can be maintained. Subjects will be tapered down from antidepressant medication prior to TMS maintenance treatment. Results will be analyzed to determine the effectiveness and feasibility of maintenance TMS therapies in a clinical setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMDD
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedSep 3, 2019
Enrollment StartSep 1, 2019
Primary CompletionSep 1, 2021
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 6.8 years ago

Interventions

TMS treatmentdevice

TMS using either a standard 10hz 20min or 3 min theta burst protocol